Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11275091 SARS-COV-2 infection biomarkers and uses thereof

Patent 11275091 was granted and assigned to CHILDREN'S HOSPITAL MEDICAL CENTER on March, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

Disclosed herein are methods that employ the use of one or more biomarkers for the treatment of SARS-CoV-2 infected individuals (COVID-19 patients). The methods may employ detection and measurement of one or more cytokines, the measurement of which may be used to treat COVID-19 patients with one or more immunomodulatory therapies.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11275091 SARS-COV-2 infection biomarkers and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo